BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38605509)

  • 1. Feasibility of
    Hung WT; Liu CJ; Liu YL; Ko KY; Chou SW; Chang HH; Yang YL; Lu MY; Hsu WM
    Pediatr Blood Cancer; 2024 Jul; 71(7):e30983. PubMed ID: 38605509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk Stratification of Pediatric Patients With Neuroblastoma Using Volumetric Parameters of 18F-FDG and 18F-DOPA PET/CT.
    Liu CJ; Lu MY; Liu YL; Ko CL; Ko KY; Tzen KY; Chang HH; Yang YL; Jou ST; Hsu WM; Yen RF
    Clin Nucl Med; 2017 Mar; 42(3):e142-e148. PubMed ID: 28072621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic performance of
    Ishiguchi H; Ito S; Kato K; Sakurai Y; Kawai H; Fujita N; Abe S; Narita A; Nishio N; Muramatsu H; Takahashi Y; Naganawa S
    Ann Nucl Med; 2018 Jun; 32(5):348-362. PubMed ID: 29667143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic FDG and FDOPA positron emission tomography scans distinguish the genomic type and treatment outcome of neuroblastoma.
    Liu YL; Lu MY; Chang HH; Lu CC; Lin DT; Jou ST; Yang YL; Lee YL; Huang SF; Jeng YM; Lee H; Miser JS; Lin KH; Liao YF; Hsu WM; Tzen KY
    Oncotarget; 2016 Apr; 7(14):18774-86. PubMed ID: 26959748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of incidental [18 F]FDG uptake in the gastrointestinal tract on PET/CT imaging: a retrospective cohort study.
    Shmidt E; Nehra V; Lowe V; Oxentenko AS
    BMC Gastroenterol; 2016 Oct; 16(1):125. PubMed ID: 27716085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 123I-MIBG scintigraphy and 18F-FDG-PET imaging for diagnosing neuroblastoma.
    Bleeker G; Tytgat GA; Adam JA; Caron HN; Kremer LC; Hooft L; van Dalen EC
    Cochrane Database Syst Rev; 2015 Sep; 2015(9):CD009263. PubMed ID: 26417712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic value of
    Feng L; Yang S; Lin Y; Li J; Cao Z; Zheng Q; Wang H; Yang J
    Pediatr Radiol; 2024 May; 54(6):954-964. PubMed ID: 38613691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of non
    Sheldon JA; Yap KK; Taubman KL; Schlicht SM
    J Med Imaging Radiat Oncol; 2018 Apr; 62(2):194-202. PubMed ID: 29230956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of
    Elmanzalawy A; Vali R; Chavhan GB; Gupta AA; Omarkhail Y; Amirabadi A; Shammas A
    Pediatr Radiol; 2020 Feb; 50(2):252-260. PubMed ID: 31628508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 18F-FDG PET/CT and 123I-metaiodobenzylguanidine imaging in high-risk neuroblastoma: diagnostic comparison and survival analysis.
    Papathanasiou ND; Gaze MN; Sullivan K; Aldridge M; Waddington W; Almuhaideb A; Bomanji JB
    J Nucl Med; 2011 Apr; 52(4):519-25. PubMed ID: 21421719
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Pattison DA; Bozin M; Gorelik A; Hofman MS; Hicks RJ; Skandarajah A
    J Nucl Med; 2018 May; 59(5):749-755. PubMed ID: 29025986
    [No Abstract]   [Full Text] [Related]  

  • 13. Role of
    Dolci C; Ceppi L; Guerra L; Crivellaro C; Lamanna M; Adorni M; Elisei F; Bonazzi CM; Sina F; Fruscio R; Messa C
    Int J Gynecol Cancer; 2019 Oct; 29(8):1298-1303. PubMed ID: 31366569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feasibility of a multimodal (18)F-FDG-directed lymph node surgical excisional biopsy approach for appropriate diagnostic tissue sampling in patients with suspected lymphoma.
    Povoski SP; Hall NC; Murrey DA; Wright CL; Martin EW
    BMC Cancer; 2015 May; 15():378. PubMed ID: 25953144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis, Treatment Response, and Prognosis: The Role of
    Piccardo A; Morana G; Puntoni M; Campora S; Sorrentino S; Zucchetta P; Ugolini M; Conte M; Cistaro A; Ferrarazzo G; Pescetto M; Lattuada M; Bottoni G; Garaventa A; Giovanella L; Lopci E
    J Nucl Med; 2020 Mar; 61(3):367-374. PubMed ID: 31541036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic Value of Metabolic Parameters and Textural Features in Pretreatment
    Wang G; Si Y; Liu J; Wang W; Yang J
    Acad Radiol; 2024 Mar; 31(3):1091-1101. PubMed ID: 37748956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. (18)F-FDG PET as a single imaging modality in pediatric neuroblastoma: comparison with abdomen CT and bone scintigraphy.
    Choi YJ; Hwang HS; Kim HJ; Jeong YH; Cho A; Lee JH; Yun M; Lee JD; Kang WJ
    Ann Nucl Med; 2014 May; 28(4):304-13. PubMed ID: 24481823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidentally found parotid gland lesion in
    Jung JH; Lee YS; Jung YH; Choi SH; Nam SY; Cho HJ; Kwon M
    BMC Surg; 2024 Apr; 24(1):124. PubMed ID: 38658868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidental ¹⁸F-FDG uptake in the thyroid in patients diagnosed with PET/CT for other malignancies.
    Czepczyński R; Stangierski A; Oleksa R; Janicka-Jedyńska M; Czarnywojtek A; Ruchała M; Sowiński J
    Nucl Med Rev Cent East Eur; 2011; 14(2):68-72. PubMed ID: 22474717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of Brain Metastases on Follow-up
    Nia ES; Garland LL; Eshghi N; Nia BB; Avery RJ; Kuo PH
    J Nucl Med Technol; 2017 Sep; 45(3):193-197. PubMed ID: 28705927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.